Abecma Coupon & Prices

Your monthly Abecma cost savings if eligible

If you are eligible for the Abecma patient assistance program, the cost of your medication will be free. We only charge $49 per month for each medication, to cover our service fees. You could receive your Abecma prescription for just $49 a month, regardless of the retail price of your medication.

Am I eligible for the Abecma patient assistance program?

We will review your application to determine whether you are eligible for the Abecma patient assistance program. Each program has its own eligibility criteria which are set by the pharmaceutical companies, however, the factors considered by most programs are:

• I am a permanent, legal resident of the United States or Puerto Rico
• I am uninsured or my insurance doesn’t cover my medication
• I meet certain income eligibility requirements

How do I apply for the Abecma patient assistance program?

We make it as easy as possible to apply for the Abecma patient assistance program. The first step is to complete our enrollment application. Tell us about any medications you are taking, including Abecma. We will also ask for details about your healthcare provider, insurance, and your household income. This information is required by the pharmaceutical manufacturers who ship your medication.

If we determine that you may be eligible for Abecma assistance, we will handle the application process for you. We will work directly with your healthcare provider to prepare your application documents. Once we have received the signed application and supporting documents, we will submit them to the patient assistance program on your behalf. Our service continues once you are enrolled in the Abecma patient assistance program, and we will automatically request your Abecma medication refills for up to 1 year.

Is NiceRx an Abecma coupons provider?

We are a service provider that helps eligible individuals access the Abecma patient assistance program. That means that we do not offer printable Abecma manufacturer coupons, Abecma discounts, or free Abecma samples. We are not an Abecma coupon provider or an Abecma discount card. Our service extends to assisting eligible individuals to access the medications they need through patient assistance programs.

Can NiceRx help me get Abecma if I have insurance?

We may be able to help you to access Abecma patient assistance in a variety of circumstances. This includes when your insurance company will not pay for your Abecma medication or if you have a high copay or coinsurance responsibility. We may also be able to help you if you do not have insurance. Please apply online to find out more.

How much does Abecma cost without insurance?

Abecma cost without insurance will vary depending on where you buy it. As a guide, Abecma intravenous suspension usually costs $438,000 for 1 suspension. With NiceRx you will pay a flat monthly fee of $49, regardless of the retail price of your medication.

How much does Abecma cost with insurance?

The copay for Abecma with insurance depends on the terms of your healthcare plan. To find out how much this is, your healthcare provider or pharmacist will be able to calculate your copay with your current insurance.

What is Abecma?

Abecma is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Celgene Corporation, a Bristol Myers Squibb (BMS) company.

Abecma is a B-cell maturation antigen (BCMA)-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory multiple myeloma after four or more prior lines of therapy, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody.

Cytokine Release Syndrome (CRS), including fatal or life-threatening reactions, occurred in patients following treatment. Do not give Abecma to patients with active infections or inflammatory disorders. Treat severe or life-threatening CRS with tocilizumab or tocilizumab and corticosteroids.

Neurologic toxicities, which may be severe or life-threatening, occurred following treatment, including concurrently with CRS, after CRS resolution, or in the absence of CRS. Monitor for neurologic events after treatment. Provide supportive care and/or corticosteroids as needed.

Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS), including fatal and life-threatening reactions, occurred in patients following treatment. HLH/MAS can occur with CRS or neurologic toxicities.

Prolonged Cytopenia with bleeding and infection, including fatal outcomes following stem cell transplantation for hematopoietic recovery, occurred following treatment.

Abecma is only available through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the Abecma REMS. Please see full Prescribing Information, including Boxed warnings and a Medication guide.

What doses of Abecma are available?

Abecma is available as a cell suspension for intravenous infusion: A single dose contains a cell suspension of 300 to 460 x 106 CAR-positive T cells in one or more infusion bags.

Abecma is made from the patient’s own T cells, so blood will be collected by a process called “leukapheresis”. You will be monitored at the healthcare facility where you receive your treatment daily for at least 7 days after the infusion.

You should stay within 2 hours of this location for at least 4 weeks after receiving treatment. Your healthcare provider will check that your treatment is working and help you with any side effects that may occur. Always speak with your caregiver about any changes to your dose so they can monitor and evaluate your condition.

Abecma active ingredients

Abecma is a type of (chimeric antigen receptor), CAR T-cell therapy targeting B-cell maturation antigen (BCMA), which is expressed on the surface of normal and malignant plasma cells. The CAR construct includes an anti-BCMA scFv-targeting domain for antigen specificity, a transmembrane domain, a CD3-zeta T cell activation domain, and a 4-1BB costimulatory domain. Antigen-specific activation of Abecma results in CAR-positive T cell proliferation, cytokine secretion, and subsequent cytolytic killing of BCMA-expressing cancer cells.

Abecma side effects

The most common side effects of Abecma in clinical trials include:

• Cytokine release syndrome – CRS
• Fatigue
• Musculoskeletal pain
• Hypogammaglobulinemia
• Diarrhea, decreased appetite, nausea
• Upper respiratory tract infection
• Encephalopathy
• Edema
• Pyrexia
• Cough, headache
• Neutropenia, leukopenia, lymphopenia, thrombocytopenia, and anemia

In rare instances, Abecma can cause more serious side effects. These can include:

• Hypersensitivity reactions
• Prolonged cytopenias
• Hypogammaglobulinemia
• Secondary malignancies

Your doctor will assess the benefits of using Abecma against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Abecma to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Abecma drug interactions

Abecma can interact with other medications. These include:

• Live vaccines – BCG, measles, mumps, rubella, smallpox
• Corticosteroids – cortisone, hydrocortisone, mometasone, prednisolone

This list is not exhaustive and other drugs may interact with Abecma.

Abecma contraindications

You should not use Abecma if you:

• Are allergic to the active ingredient idecabtagene vicleucel (ide-cel)
• Are allergic to any of the other ingredients in Abecma

Talk to your doctor before using Abecma if you:

• Are taking any of the medications that could interact with Abecma
• Are pregnant or are planning to become pregnant
• Are breastfeeding or are planning to breastfeed

Abecma generic

Abecma is the trademark brand name for idecabtagene vicleucel manufactured by Celgene Corporation, a Bristol Myers Squibb company. A generic version of idecabtagene vicleucel is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Abecma savings through NiceRx.